BEIJING— Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China, the biggest such penalty ever imposed by a Chinese court. The court sentenced the company's former China manager, Briton Mark Reilly, and four Chinese co-defendants to prison but postponed the sentences for two to four years, suggesting they may never be served.» Read More
The FMHR traders discuss whether China or Europe is a bigger concern for global investors amid weak PMI data. Also, does a pullback in Wal-Mart shares present a buying opportunity for investors? David Strasser, Janney Capital Markets retail analyst, weighs in.
Jorge Castaneda, former Foreign Minister of Mexico and NYU professor, discusses the Wal-Mart bribery scandal and conducting business south of the border.
Patrick McKeever, MKM Partners senior equity analyst, discusses the importance of the Mexican markets for Wal-Mart's growth and the impact the alleged scandal could have on the company's stock and executives.
CNBC's Michelle Caruso-Cabrera reports on the culture of doing business in Mexico, saying Wal-Mart is the largest private employer in Mexico and yet, barely any newspapers carried the story on the front page.
The Squawk on the Street team report on the issues facing the Street ahead of Monday's open, and Jim Cramer weighs in on Wal-Mart's alleged bribery investigation in Mexico.
CNBC's Michelle Caruso-Cabrera and Scott Cohn provide the latest details on Wal-Mart's efforts to make a bribery case go away and the crackdown on foreign corruption. Also, a look inside Wal-Mart's culture, with CNBC's David Faber.
Jacob Frenkel, former SEC enforcement attorney, discusses the consequences Wal-Mart could face following allegations it tried to cover up a bribery investigation in Mexico.
CNBC's Courtney Reagan reports the latest details and fallout from an alleged bribery scandal in Mexico that hit Wal-Mart years ago.
Did Wal-Mart's Mexican division orchestrate a campaign of bribery to grab market dominance? Jeffrey Sonnenfeld, Yale School of Management weighs in on the investigation.
Dozens of foreign companies with London listings may be exempt from new anti-corruption laws, Ken Clarke has confirmed, a disclosure that will anger investors keen to preserve the integrity of London’s markets, the Financial Times reports.